Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
분석가 평가, 목표 가격, 예측
Micron Technology Inc의 합의된 목표 주가는 30명의 최신 애널리스트 평가를 바탕으로 설정되었습니다. 최고 목표가는 10월 27, 2025에 Citigroup에서 발표한 $275이며, 최저 목표가는 3월 26, 2025에 China Renaissance에서 발표한 $84입니다. 10월 28, 2025, 10월 27, 2025 및 10월 20, 2025에 Mizuho, Citigroup 및 Barclays에서 발표한 3명의 최근 애널리스트 평가가 있습니다. Mizuho, Citigroup 및 Barclays 사이의 평균 목표 주가는 $260이며, 이러한 3명의 최근 애널리스트 평가로부터 Micron Technology Inc에 대한 암시된 14.04% upside가 있습니다.
추천을 하는 애널리스트 회사들1
Mizuho
Citigroup
Barclays
UBS
Goldman Sachs
1애널리스트 평가로부터 계산됨
Micron Technology에 대한 애널리스트 평점
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/28/2025 | 16.23% | Mizuho | $240 → $265 | Maintains | Outperform | |||
10/27/2025 | 20.62% | Citigroup | $240 → $275 | Maintains | Buy | |||
10/20/2025 | 5.27% | Barclays | $195 → $240 | Maintains | Overweight | |||
10/17/2025 | 5.27% | Mizuho | $195 → $240 | Maintains | Outperform | |||
10/16/2025 | 7.46% | UBS | $225 → $245 | Maintains | Buy | |||
10/16/2025 | 5.27% | Citigroup | $200 → $240 | Maintains | Buy | |||
10/14/2025 | — | New Street Research | — | Downgrade | Buy → Neutral | |||
10/09/2025 | -21.05% | Goldman Sachs | $145 → $180 | Maintains | Neutral | |||
10/08/2025 | -1.31% | UBS | $195 → $225 | Maintains | Buy | |||
10/07/2025 | 9.21% | Itau BBA | — | → $249 | Initiates | → Outperform | ||
10/06/2025 | -3.51% | Morgan Stanley | $160 → $220 | Upgrade | Equal-Weight → Overweight | |||
09/24/2025 | -12.28% | Deutsche Bank | $175 → $200 | Maintains | Buy | |||
09/24/2025 | -36.4% | Goldman Sachs | $130 → $145 | Maintains | Neutral | |||
09/24/2025 | -14.47% | Stifel | $173 → $195 | Maintains | Buy | |||
09/24/2025 | -16.66% | Raymond James | $150 → $190 | Reiterates | Outperform → Outperform | |||
09/24/2025 | -12.28% | Piper Sandler | $165 → $200 | Reiterates | Overweight → Overweight | |||
09/24/2025 | -12.28% | TD Cowen | $180 → $200 | Maintains | Buy | |||
09/24/2025 | -14.47% | UBS | $185 → $195 | Maintains | Buy | |||
09/24/2025 | -12.28% | Citigroup | $175 → $200 | Maintains | Buy | |||
09/24/2025 | -14.47% | Mizuho | $182 → $195 | Maintains | Outperform | |||
09/24/2025 | -3.51% | Wedbush | $200 → $220 | Maintains | Outperform | |||
09/24/2025 | -3.51% | Wells Fargo | $170 → $220 | Maintains | Overweight | |||
09/24/2025 | -14.47% | Barclays | $175 → $195 | Maintains | Overweight | |||
09/24/2025 | -3.51% | JP Morgan | $185 → $220 | Maintains | Overweight | |||
09/24/2025 | -21.05% | B of A Securities | $140 → $180 | Maintains | Neutral | |||
09/24/2025 | -5.7% | Keybanc | $160 → $215 | Maintains | Overweight | |||
09/24/2025 | 9.65% | Rosenblatt | $200 → $250 | Maintains | Buy | |||
09/24/2025 | -12.28% | Needham | $150 → $200 | Maintains | Buy | |||
09/22/2025 | -29.82% | Morgan Stanley | $135 → $160 | Maintains | Equal-Weight | |||
09/22/2025 | -24.12% | Stifel | $145 → $173 | Maintains | Buy | |||
09/19/2025 | -23.24% | Barclays | $140 → $175 | Maintains | Overweight | |||
09/18/2025 | -12.28% | Wedbush | $165 → $200 | Maintains | Outperform | |||
09/18/2025 | -12.28% | Rosenblatt | $200 → $200 | Maintains | Buy | |||
09/17/2025 | -12.28% | Susquehanna | $160 → $200 | Maintains | Positive | |||
09/17/2025 | -21.05% | Wolfe Research | $160 → $180 | Maintains | Outperform | |||
09/16/2025 | -20.17% | Mizuho | $155 → $182 | Maintains | Outperform | |||
09/15/2025 | -23.24% | Deutsche Bank | $150 → $175 | Maintains | Buy | |||
09/15/2025 | -18.86% | UBS | $155 → $185 | Maintains | Buy | |||
09/15/2025 | -18.86% | Cantor Fitzgerald | $155 → $185 | Maintains | Overweight | |||
09/11/2025 | -23.24% | Citigroup | $150 → $175 | Maintains | Buy | |||
08/27/2025 | -32.02% | CLSA | → $155 | Initiates | → Outperform | |||
08/12/2025 | -18.86% | JP Morgan | $165 → $185 | Maintains | Overweight | |||
08/11/2025 | -12.28% | Rosenblatt | $200 → $200 | Maintains | Buy | |||
08/11/2025 | -34.21% | Needham | $150 → $150 | Reiterates | Buy → Buy | |||
07/10/2025 | -34.21% | Deutsche Bank | → $150 | Initiates | → Buy | |||
07/10/2025 | -42.98% | Goldman Sachs | → $130 | Initiates | → Neutral | |||
06/27/2025 | -12.28% | Baird | $163 → $200 | Maintains | Outperform | |||
06/26/2025 | -29.82% | Susquehanna | $150 → $160 | Maintains | Positive | |||
06/26/2025 | -36.4% | Stifel | $130 → $145 | Maintains | Buy | |||
06/26/2025 | -27.63% | Piper Sandler | $120 → $165 | Reiterates | Overweight → Overweight | |||
06/26/2025 | -34.21% | Raymond James | $120 → $150 | Maintains | Outperform | |||
06/26/2025 | -29.82% | Keybanc | $135 → $160 | Maintains | Overweight | |||
06/26/2025 | -25.44% | Wells Fargo | $150 → $170 | Maintains | Overweight | |||
06/26/2025 | -32.02% | UBS | $120 → $155 | Maintains | Buy | |||
06/26/2025 | -40.79% | Morgan Stanley | $98 → $135 | Maintains | Equal-Weight | |||
06/26/2025 | -34.21% | Citigroup | $130 → $150 | Maintains | Buy | |||
06/26/2025 | -27.63% | Wedbush | $150 → $165 | Maintains | Outperform | |||
06/26/2025 | -32.02% | Cantor Fitzgerald | $145 → $155 | Maintains | Overweight | |||
06/26/2025 | -38.6% | Barclays | $95 → $140 | Maintains | Overweight | |||
06/26/2025 | -38.6% | B of A Securities | $84 → $140 | Maintains | Neutral | |||
06/26/2025 | -27.63% | JP Morgan | $135 → $165 | Maintains | Overweight | |||
06/26/2025 | -34.21% | Needham | $120 → $150 | Maintains | Buy | |||
06/26/2025 | -12.28% | Rosenblatt | $172 → $200 | Maintains | Buy | |||
06/23/2025 | -24.56% | Rosenblatt | $172 → $172 | Maintains | Buy | |||
06/20/2025 | -34.21% | Wedbush | $130 → $150 | Maintains | Outperform | |||
06/20/2025 | -34.21% | Wells Fargo | $130 → $150 | Maintains | Overweight | |||
06/09/2025 | -42.98% | Citigroup | $110 → $130 | Maintains | Buy | |||
06/05/2025 | -42.98% | Mizuho | $124 → $130 | Maintains | Outperform | |||
06/05/2025 | -47.37% | UBS | $92 → $120 | Maintains | Buy | |||
05/07/2025 | -57.02% | Morgan Stanley | $112 → $98 | Maintains | Equal-Weight | |||
04/28/2025 | -59.65% | UBS | $130 → $92 | Maintains | Buy | |||
04/22/2025 | -58.33% | Barclays | $115 → $95 | Maintains | Overweight | |||
04/16/2025 | -63.16% | B of A Securities | $110 → $84 | Maintains | Neutral | |||
04/11/2025 | -51.75% | Citigroup | $120 → $110 | Maintains | Buy | |||
03/26/2025 | -63.16% | China Renaissance | → $84 | Downgrade | Buy → Hold | |||
03/21/2025 | -45.61% | Mizuho | $115 → $124 | Maintains | Outperform | |||
03/21/2025 | -47.37% | Citigroup | $150 → $120 | Maintains | Buy | |||
03/21/2025 | -49.56% | Barclays | $110 → $115 | Maintains | Overweight | |||
03/21/2025 | -50.88% | Morgan Stanley | $91 → $112 | Maintains | Equal-Weight | |||
03/21/2025 | -40.79% | JP Morgan | $145 → $135 | Maintains | Overweight | |||
03/21/2025 | -42.98% | Wedbush | $125 → $130 | Maintains | Outperform | |||
03/21/2025 | -42.98% | Cantor Fitzgerald | $130 → $130 | Reiterates | Overweight → Overweight | |||
03/21/2025 | -28.51% | Baird | $130 → $163 | Maintains | Outperform | |||
03/21/2025 | -12.28% | Rosenblatt | $250 → $200 | Maintains | Buy | |||
03/19/2025 | -49.56% | Mizuho | $115 → $115 | Maintains | Outperform | |||
03/17/2025 | -42.98% | UBS | $125 → $130 | Maintains | Buy | |||
03/17/2025 | -45.17% | Wedbush | $125 → $125 | Reiterates | Outperform → Outperform | |||
03/13/2025 | -42.98% | Wells Fargo | $140 → $130 | Maintains | Overweight | |||
01/28/2025 | -60.09% | Morgan Stanley | $98 → $91 | Maintains | Equal-Weight | |||
12/20/2024 | -51.75% | Barclays | $145 → $110 | Maintains | Overweight | |||
12/19/2024 | -47.37% | Raymond James | $140 → $120 | Maintains | Outperform | |||
12/19/2024 | -47.37% | Piper Sandler | $150 → $120 | Maintains | Overweight | |||
12/19/2024 | -57.02% | Morgan Stanley | $114 → $98 | Maintains | Equal-Weight | |||
12/19/2024 | -45.17% | TD Cowen | $135 → $125 | Maintains | Buy | |||
12/19/2024 | -36.4% | JP Morgan | $180 → $145 | Maintains | Overweight | |||
12/19/2024 | -42.98% | Cantor Fitzgerald | $150 → $130 | Maintains | Overweight | |||
12/19/2024 | -42.98% | Stifel | $135 → $130 | Maintains | Buy | |||
12/19/2024 | -43.86% | Goldman Sachs | $145 → $128 | Maintains | Buy | |||
12/19/2024 | -38.6% | Wells Fargo | $175 → $140 | Maintains | Overweight | |||
12/19/2024 | -45.17% | UBS | $135 → $125 | Maintains | Buy |
FAQ
Micron Technology (MU) 주식의 목표 가격은 얼마입니까?
Micron Technology (NASDAQ:MU)의 최신 목표 주가는 10월 28, 2025에 Mizuho에 의해 보고되었습니다. 이 애널리스트 기관은 $265.00에 대한 가격 목표를 설정했으며, 12개월 이내에 MU이(가) rise될 것으로 예상합니다 (가능한 16.25% upside). 지난 1년간 100개의 애널리스트 기관이 평가를 보고했습니다.
Micron Technology (MU)에 대한 가장 최근의 애널리스트 평가는 무엇인가요?
Micron Technology (NASDAQ:MU)에 대한 최신 애널리스트 평가는 Mizuho에 의해 제공되었으며, Micron Technology은(는) outperform 평가를 유지했다합니다.
Micron Technology (MU)에 대한 마지막 업그레이드는 언제 있었나요?
Micron Technology Inc에 대한 마지막 업그레이드는 10월 6, 2025에 발생했습니다. 이 때 Morgan Stanley는 $220로 가격 목표를 올렸습니다. Morgan Stanley는 이전에 Micron Technology Inc에 대해 an equal-weight를 가지고 있었습니다.
Micron Technology (MU)에 대한 마지막 다운그레이드는 언제 있었나요?
Micron Technology Inc에 대한 마지막 다운그레이드는 10월 14, 2025에 발생했습니다. 이 때 New Street Research가 Micron Technology Inc에 대해 가격 목표를 N/A에서 N/A로 변경했습니다.
Micron Technology (MU)에 대한 다음 애널리스트 평가는 언제 게시 또는 업데이트될 예정인가요?
애널리스트들은 주식 평가를 내리기 위해 철저한 연구를 진행합니다. 이 연구에는 공개된 재무 보고서를 검토하고, Micron Technology의 경영진 및 고객과 대화하며, 실적 회의 통화를 듣는 것이 포함됩니다. 대부분의 애널리스트들은 이를 매 분기마다 수행하므로, 한 해에는 회사당 애널리스트 당 4번의 평가를 받을 수 있습니다. Micron Technology에 대한 마지막 평가는 10월 28, 2025에 제출되었으므로, 다음 평가가 10월 28, 2026쯤에 제공될 것으로 예상됩니다.
애널리스트 평가 Micron Technology (MU)가 올바른가요?
평가는 주관적이며 변할 수 있지만, 최신 Micron Technology (MU) 평가는 유지했다로, 가격 목표는 $240.00에서 $265.00으로 조정되었습니다. 현재 Micron Technology (MU)의 가격은 $227.96로, 이는 애널리스트의 예측 범위에서 out of입니다.
검색 애널리스트 평가 및 가격 목표 모든 주식에 대한
사람들이 또한 지켜본다
© 2025 Benzinga | All Rights Reserved